Gastro-esophageal Junction Adenocarcinoma
6 clinical trials · Condition
◉ Watch Gastro-esophageal Junction Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma (NCT03141034) | Washington University School of Medicine | 2017-11-01 |
| FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma (NCT03283761) | Al B. Benson, III, MD | 2017-09-21 |
Track Gastro-esophageal Junction Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.